当前位置:
X-MOL 学术
›
Ann. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Anti-EGFR plus chemotherapy in unselected advanced oesophageal squamous cell carcinoma: less POWERful than expected.
Annals of Oncology ( IF 50.5 ) Pub Date : 2020-02-01 , DOI: 10.1016/j.annonc.2019.11.009 C Connell 1 , E C Smyth 1
中文翻译:
未选择的晚期食道鳞状细胞癌中的抗EGFR联合化疗:功效比预期的要弱。
更新日期:2020-02-01
Annals of Oncology ( IF 50.5 ) Pub Date : 2020-02-01 , DOI: 10.1016/j.annonc.2019.11.009 C Connell 1 , E C Smyth 1
Affiliation
中文翻译:
未选择的晚期食道鳞状细胞癌中的抗EGFR联合化疗:功效比预期的要弱。